Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Argent Biopharma Limited
RGTCurrent price
0.32 AUD
-0.035 AUD (-9.86%)
Last closed
0.33 AUD
Company
mgcpharma.com.au
ISIN
AU000000MXC6
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Australian Securities Exchange
Capitalization
15 581 082 AUD
Yield for 12 month
-84.00 %
1Y
3Y
5Y
10Y
15Y
RGT
Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia. Address: 295 Rokeby Road, Subiaco, WA, Australia, 6008
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
29.56 AUDP/E ratio
–Dividend Yield
–Current Year
+3 355 108 AUD
Last Year
+4 686 671 AUD
Current Quarter
+593 789 AUD
Last Quarter
+717 977 AUD
Current Year
+692 044 AUD
Last Year
+1 547 234 AUD
Current Quarter
-576 842 AUD
Last Quarter
-160 114 AUD
Key Figures RGT
1 year
3 years
5 years
10 years
EBITDA
-17 334 505 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-108.58 %
PEG Ratio
–
Return On Equity TTM
-307.4 %
Wall Street Target Price
29.56 AUD
Revenue TTM
882 545 AUD
Book Value
-0.11 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-59.8 %
Dividend Yield
–
Gross Profit TTM
1 274 136 AUD
Earnings per share
-0.47 AUD
Diluted Eps TTM
-0.47 AUD
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics RGT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:1000
Payout Ratio
–
Last Split Date
30.10.2023
Dividend Date
–
Stock Valuation RGT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
14.9031
Enterprise Value Revenue
10.2268
Price Sales TTM
17.6547
Enterprise Value EBITDA
-1.6171
Price Book MRQ
9.8519
Financials RGT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RGT
For 52 weeks
0.15 AUD
2.97 AUD
50 Day MA
0.3 AUD
Shares Short Prior Month
–
200 Day MA
0.34 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart